JPMorgan Resumes Coverage on MedAssets (MDAS) at Neutral
MDAS Hot Sheet
Rating Summary:8 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 7 | New: 23
JPMorgan resumes coverage on MedAssets (NASDAQ: MDAS) with a Neutral rating and a price target of $23.
For more ratings news on MedAssets click here and for the rating history of MedAssets click here.
Shares of MedAssets closed at $19.48 yesterday, with a 52 week range of $17.35-$25.08.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
For more ratings news on MedAssets click here and for the rating history of MedAssets click here.
Shares of MedAssets closed at $19.48 yesterday, with a 52 week range of $17.35-$25.08.
Discover Wall Street's best ratings calls with the pros - Upgrade to Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- UPDATE: William Blair Starts EPIQ Systems (EPIQ) at Outperform; Broad Suite of Solutions in Electronic Discovery Sector
- Wunderlich Securities Starts Anixter International (AXE) at Buy
- Evercore Partners Starts Golar LNG Ltd. (GLNG) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
